Drug Insomnia Newly Approved

Quviviq to treat insomnia

Drug Name: Quviviq

Indications: To treat insomnia.

Active Ingredient: Daridorexant

Company: Idorsia Pharmaceuticals US Inc

Approval Date: 1/7/2022

More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214985s000lbl.pdf

Related

Drug Practice Process Research

Elevating Healthcare Conversations through AI-Enabled CI: KAI Conversations

Drug Practice Process Research

Revolutionizing Pharmacovigilance with AI: DrugCard

Drug Practice Procedure Process Research

Solving for Precision Medicine with AI-Enabled Solutions: Tempus